Marie Anne Ledingham: key facts
- Kind of voice
- Clinician
- Role
- consultant clinical advisor for women's and reproductive health at NICE
- Quoted on
- Women's health & gynaecology
- Press citations held
- 2
- Most recently quoted
- 30 Sept 2026
“This new guideline will help improve consistency of care, increase awareness of the condition, and support earlier diagnosis and management.”
What Marie Anne Ledingham has said
“For a lot of the other medical conditions [other than that of stroke], there wasn't sufficient evidence available on individual formulations of HRT, and that has been passed on to our surveillance team at Nice, so that, when the guideline is updated in the future, we will be able to make individual recommendations about each specific type of HRT and, in particular, different types of progesterone and how that is delivered, whether it's as a Mirena coil, or whether it's as the newer forms of micronised progesterone.”
Consultant clinical adviser at Nice · Women's health & gynaecology · 29 Sept 2026 · HRT should be offered as first-line treatment for menopause, says Nice ↗
Where Marie Anne Ledingham has been quoted
- Women with PMOS should have yearly NHS checks, says health watchdogbbc.co.uk · 30 Sept 2026
- HRT should be offered as first-line treatment for menopause, says Nicetheguardian.com · 29 Sept 2026
Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 30 Sept 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.